2331 related articles for article (PubMed ID: 29151695)
21. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study.
Xu X; Chen R; Chen Q; An K; Ding L; Zhang L; Wang F; Deng Y
Complement Ther Clin Pract; 2021 May; 43():101359. PubMed ID: 33711747
[TBL] [Abstract][Full Text] [Related]
23. Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.
Zhang W; Lai SL; Chen J; Xie D; Wu FX; Jin GQ; Su DK
World J Gastroenterol; 2017 Sep; 23(35):6467-6473. PubMed ID: 29085196
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.
Zhao H; Chen C; Fu X; Yan X; Jia W; Mao L; Jin H; Qiu Y
Oncotarget; 2017 Jan; 8(3):5474-5486. PubMed ID: 27729623
[TBL] [Abstract][Full Text] [Related]
26. Prognostic predictors for patients with hepatocellular carcinoma receiving adjuvant transcatheter arterial chemoembolization.
Gu J; Zhang X; Cui R; Zhang J; Wang Z; Jia Y; Miao R; Dong Y; Ma X; Fan H; Wang H; Ren L; Li Y; Niu W; Zhang J; Qu K; Liu C
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):836-844. PubMed ID: 30614882
[TBL] [Abstract][Full Text] [Related]
27. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.
Huang C; Zhu XD; Ji Y; Ding GY; Shi GM; Shen YH; Zhou J; Fan J; Sun HC
BMC Cancer; 2017 Jan; 17(1):58. PubMed ID: 28095820
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
Kodama K; Kawaoka T; Aikata H; Uchikawa S; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K
J Gastroenterol Hepatol; 2018 Oct; 33(10):1780-1786. PubMed ID: 29645345
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study.
Wang Z; Ren Z; Chen Y; Hu J; Yang G; Yu L; Yang X; Huang A; Zhang X; Zhou S; Sun H; Wang Y; Ge N; Xu X; Tang Z; Lau W; Fan J; Wang J; Zhou J
Clin Cancer Res; 2018 May; 24(9):2074-2081. PubMed ID: 29420221
[No Abstract] [Full Text] [Related]
30. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
[TBL] [Abstract][Full Text] [Related]
31. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant transarterial chemoembolization after curative hepatectomy for hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
Shen A; Liu M; Zheng D; Chen Q; Wu Z
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):142-154. PubMed ID: 31303533
[TBL] [Abstract][Full Text] [Related]
33. Microvascular invasion may be the determining factor in selecting TACE as the initial treatment in patients with hepatocellular carcinoma.
Jeong J; Park JG; Seo KI; Ahn JH; Park JC; Yun BC; Lee SU; Lee JW; Yun JH
Medicine (Baltimore); 2021 Jul; 100(27):e26584. PubMed ID: 34232206
[TBL] [Abstract][Full Text] [Related]
34. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
[TBL] [Abstract][Full Text] [Related]
35. Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma.
Nishikawa H; Arimoto A; Wakasa T; Kita R; Kimura T; Osaki Y
Int J Oncol; 2013 Jan; 42(1):151-60. PubMed ID: 23174998
[TBL] [Abstract][Full Text] [Related]
36. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
[TBL] [Abstract][Full Text] [Related]
37. Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization.
Ciria R; López-Cillero P; Gallardo AB; Cabrera J; Pleguezuelo M; Ayllón MD; Luque A; Zurera L; Espejo JJ; Rodríguez-Perálvarez M; Montero JL; de la Mata M; Briceño J
Eur J Surg Oncol; 2015 Sep; 41(9):1153-61. PubMed ID: 26118317
[TBL] [Abstract][Full Text] [Related]
38. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
[TBL] [Abstract][Full Text] [Related]
39. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.
Zhao WC; Fan LF; Yang N; Zhang HB; Chen BD; Yang GS
Eur J Surg Oncol; 2013 Aug; 39(8):858-64. PubMed ID: 23669199
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis.
Jiang JH; Guo Z; Lu HF; Wang XB; Yang HJ; Yang FQ; Bao SY; Zhong JH; Li LQ; Yang RR; Xiang BD
World J Gastroenterol; 2015 Apr; 21(15):4627-34. PubMed ID: 25914472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]